Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 8, 2012, Pages 614-621

  Tan, Rongwei ^a   She, Zhending ^a   Wang, Mingbo ^a   Yu, Xing ^b   Jin, He ^b,c   Feng, Qingling ^a  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Traditional Chinese Medicine Hospital of Yanqing County   (China)

Author keywords

Bone regeneration; Controlled release; Critical size defect; Marrow mesenchymal stem cells; Micro CT; Rat calvarial bone; RhBMP 2, injectable

Indexed keywords

BIOACTIVITY; BODY FLUIDS; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; DEFECTS; HYDROXYAPATITE; NANOCOMPOSITES; PHOSPHATASES; RECOMBINANT PROTEINS; REPAIR; STEM CELLS;

BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; CALVARIAL BONES; CONTROLLED RELEASE; CRITICAL SIZE DEFECT; INJECTABLES; MARROW MESENCHYMAL STEM CELLS; MICRO CT; RAT CALVARIAL BONE; RHBMP-2, INJECTABLE;

RATS;

ALKALINE PHOSPHATASE; BOVINE SERUM ALBUMIN; COLLAGEN; DRUG CARRIER; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; COMPOSITE MATERIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INJECTABLE BONE REGENERATION COMPOSITE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; SKULL DEFECT;

EID: 84864312695     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.463     Document Type: Article

References (33)

1. Ahn SH, Kim CS, Suk HJ, et al. 2003; Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol 74: 787-797
2. Bessa PC, Casal M, Reis RL, et al. 2008a; Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
3. Bessa PC, Casal M, Reis RL, et al. 2008b; Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2: 1-13.
4. Bulpitt P, Aeschlimann D. 1999; New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 47: 152-169.
5. Canter HI, Vargel I, Korkusuz P, et al. 2010; Effect of use of slow release of bone morphogenetic protein-2 and transforming growth factor-β2 in a chitosan gel matrix on cranial bone graft survival in experimental cranial critical size defect model. Ann Plast Surg 64: 342-350.
6. Du C, Cui FZ, Zhang W, et al. 2000; Formation of calcium phosphate/collagen composites through mineralization of collagen matrix. J Biomed Mater Res 50: 518-527.
7. Efeoglu C, Burke JL, Parsons AJ, et al. 2009; Analysis of calvarial bone defects in rats using microcomputed tomography: potential for a novel composite material and a new quantitative measurement. Br J Oral Max Surg 47: 616-621.
8. Hong SJ, Kim CS, Han DK, et al. 2006; The effect of a fibrin-fibronectin/β-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 27: 3810-3816.
9. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, et al. 2007; Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 117: 380-386.
10. Hou QP, De Bank PA, Shakesheff KM, et al. 2004; Injectable scaffolds for tissue regeneration. J Mater Chem 14: 1915-1923.
11. Kim HD, Valentini RF. 2002; Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59: 573-584.
12. Liao SS, Cui FZ, Zhang W, et al. 2004; Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite. J Biomed Mater Res B 69: 158-165.
13. Luca L, Capelle MAH, Machaidze G, et al. 2010a; Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhB MP-2). Int J Pharmaceut 391: 48-54.
14. Luca L, A-L Rougemont, Beat H, et al. 2010b; The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J Control Release 147: 38-44.
15. Mallapragada SK, Narasimhan B. 2002; Injectable polymeric biomaterials. Biomaterials 23(special issue): 4305-4305.
16. Niu XF, Feng QL, Wang MB, et al. 2009; Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release 134: 111-117.
17. Pang EK, Im SU, Kim CS, et al. 2004; Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model. J Periodontol 75: 1364-1370.
18. Por YC, Barcelo CR, Salyer KE, et al. 2008; Bone generation in the reconstruction of a critical size calvarial defect in an experimental model. J Craniofac Surg 19: 383-392.
19. Rinaudo M. 2008; Main properties and current applications of some polysaccharides as biomaterials. Polym Int 57: 397-430.
20. Saito N, Murakami N, Takahashi J, et al. 2005; Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliver Rev 57: 1037-1048.
21. Seeherman H, Wozney JM. 2005; Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16: 329-345.
22. Shen H, Hu XX, Yang F, et al. 2010; An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomater 6: 455-465.
23. Shin H, Jo S, Mikos AG, et al. 2003; Biomimetic materials for tissue engineering. Biomaterials 24: 4353-4364.
24. Tan R, Feng Q, She ZD, et al. 2011; Structure and biocompatibility of an injectable bone regeneration composite. J Biomat Sci Polym E 22: 1861-1879.
25. Tan RW, Niu XF, Gan SL, et al. 2009; Preparation and characterization of an injectable composite. J Mater Sci Mater M 20: 1245-1253.
26. Tonnesen HH, Karlsen J. 2002; Alginate in drug delivery systems. Drug Dev Ind Pharm 28: 621-630.
27. Wang EA, Rosen V, Dalessandro JS, et al. 1990; Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224.
28. Wang MB, Feng QL, Niu XF, et al. 2010; A spheres-in-sphere structure for improving protein-loading poly(lactide-co-glycolide) microspheres. Polym Degrad Stabil 95: 6-13.
29. Wei GB, Jin QM, Giannobile WV, et al. 2007; The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28: 2087-2096.
30. Wozney JM, Rosen V. 1998; Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 346: 26-37.
31. Yamamoto M, Takahashi Y, Tabata Y, et al. 2006; Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12: 1305-1311.
32. Zhang W, Liao SS, Cui FZ, et al. 2003; Hierarchical self-assembly of nano-fibrils in mineralized collagen. Chem Mater 15: 3221-3226.
33. Zhao Y, Li F, Harris MT, et al. 2009; Interactions between bovine serum albumin and alginate: an evaluation of alginate as protein carrier. J Colloid Interf Sci 332: 345-353.